MedTrace Logo

Organoids From Metastases of Prostate Cancer

NCT03952793 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-11-01

No results posted yet for this study

Summary

The aim of the study is the development of the organoid culture technique from metastases from patients with advanced form of prostate cancer. Once the technique is set up, the organoid will serve to test several antitumor molecules.

Conditions

  • Prostatic Neoplasm

Interventions

OTHER

extended biopsy

Additional sample are performed during a biopsy to provide tumor tissues for the organoid technique development

Sponsors & Collaborators

  • Centre Méditerranéen de Médecine Moléculaire UMR_S-1065

    collaborator UNKNOWN

  • Centre Antoine Lacassagne

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2021-10-25
Completion
2021-10-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03952793 on ClinicalTrials.gov